GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.

dc.authorid0000-0002-7059-1411
dc.authorwosidLee, Kee-Joon/AAA-4090-2022
dc.authorwosidGraklanov, Vasko/AAB-8273-2020
dc.authorwosidRadinoff, Atanas/AAD-8721-2021
dc.contributor.authorErtan-Ahmed, Senem
dc.contributor.authorKiehl, Michael G.
dc.contributor.authorRadinoff, Atanas
dc.contributor.authorGraklanov, Vasko
dc.contributor.authorTzvetkov, Nikolay
dc.contributor.authorMihaescu, Rodica
dc.contributor.authorSung, Young Chul
dc.contributor.authorTurgut, Burhan
dc.date.accessioned2022-05-11T14:39:57Z
dc.date.available2022-05-11T14:39:57Z
dc.date.issued2019
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL
dc.description.abstract[No Abstract Available]
dc.description.sponsorshipAmer Soc Clin Oncol
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8811
dc.identifier.volume37
dc.identifier.wosWOS:000487345802410
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorTurgut, Burhan
dc.language.isoen
dc.publisherAmer Soc Clinical Oncology
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleGX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.
dc.typeConference Object

Dosyalar